Sustained release isoniazid tablets. I--Formulation and in vitro evaluation. 1989

F Bulut-Oner, and Y Capan, and S Kas, and L Oner, and A A Hincal
Pharmaceutical Technology Department, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.

Isoniazid (INH) has been widely used in the preventive therapy of tuberculosis since the early 1950's. The aim in designing a sustained release tablet form was to attain in fast inactivators sustained blood concentrations similar to those produced by ordinary INH tablets in slow acetylators during chemotherapy. In the present paper, the release of INH incorporated into three different matrix materials, polymethylmethacrylates, polyvinyl chloride and carbomer were studied. The release rate of a unit dose of conventionally formulated INH tablets was used as a basis of comparison. The best sustained effect on the release rate of INH was obtained with 30% carbomer matrix tablets.

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008768 Methylmethacrylates The methyl esters of methacrylic acid that polymerize easily and are used as tissue cements, dental materials, and absorbent for biological substances.
D011143 Polyvinyl Chloride A polyvinyl resin used extensively in the manufacture of plastics, including medical devices, tubing, and other packaging. It is also used as a rubber substitute. Chloroethylene Polymer,Polychloroethylene,Vinyl Chloride Polymer,Chloroethylene Homopolymer,Geon,PVC,Ultron,Viaflex,Vinylite,Chloride, Polyvinyl,Homopolymer, Chloroethylene,Polymer, Chloroethylene,Polymer, Vinyl Chloride
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004339 Drug Compounding The preparation, mixing, and assembly of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814). Drug Formulation,Drug Preparation,Drug Microencapsulation,Pharmaceutical Formulation,Compounding, Drug,Formulation, Drug,Formulation, Pharmaceutical,Microencapsulation, Drug,Preparation, Drug
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D013229 Stearic Acids A group of compounds that are derivatives of octadecanoic acid which is one of the most abundant fatty acids found in animal lipids. (Stedman, 25th ed) Dihydrooleic Acids,Octadecanoic Acids,Tetrahydrolinoleic Acids,Acids, Dihydrooleic,Acids, Octadecanoic,Acids, Stearic,Acids, Tetrahydrolinoleic

Related Publications

F Bulut-Oner, and Y Capan, and S Kas, and L Oner, and A A Hincal
March 1981, Journal of clinical and hospital pharmacy,
F Bulut-Oner, and Y Capan, and S Kas, and L Oner, and A A Hincal
January 1980, Pharmaceutica acta Helvetiae,
F Bulut-Oner, and Y Capan, and S Kas, and L Oner, and A A Hincal
April 1990, Pharmaceutical research,
F Bulut-Oner, and Y Capan, and S Kas, and L Oner, and A A Hincal
December 2003, AAPS PharmSciTech,
F Bulut-Oner, and Y Capan, and S Kas, and L Oner, and A A Hincal
September 2008, Drug delivery,
F Bulut-Oner, and Y Capan, and S Kas, and L Oner, and A A Hincal
March 2013, Acta pharmaceutica (Zagreb, Croatia),
F Bulut-Oner, and Y Capan, and S Kas, and L Oner, and A A Hincal
July 2020, AAPS PharmSciTech,
F Bulut-Oner, and Y Capan, and S Kas, and L Oner, and A A Hincal
March 2017, Pakistan journal of pharmaceutical sciences,
F Bulut-Oner, and Y Capan, and S Kas, and L Oner, and A A Hincal
March 2012, Journal of pharmacy & bioallied sciences,
F Bulut-Oner, and Y Capan, and S Kas, and L Oner, and A A Hincal
June 2000, Drug development and industrial pharmacy,
Copied contents to your clipboard!